Thursday, January 18, 2007





| |
|
|
Created by: Tornado Staff

Top 10 investments since 2004
Three venture capital deals of €49 million and more have already been announced in 2007, placing these deals among the largest recorded by Tornado Insider Research. In the past three years (as from January 2004), the Top 10 investments in European and Israeli technology companies alone have raised a whopping €563 million. The three 2007 deals (Plastic Logic, Novexel and Movetis) are part of this listing, placed in positions 1, 5 and 6, respectively. For details of the Top 10, please see below:

Two 2006 investments are included in this Top 10, with Alma Lasers claiming second position. The company specializes in laser, light and radiofrequency-based systems for the aesthetic medical market. Since the investment was announced it released a Pixel 2940 Module for its Harmony platform, moved into new facilities at its Israel-based headquarters and relocated its US facilities from Fort Lauderdale to Chicago. Chroma Therapeutics (No. 9) focuses on small molecule drugs based upon chromatin biology and novel cell accumulation approaches. It has stayed out of the limelight since its investment, working to develop its lead program.
2005 can boast three Top 10 investments with Actix in 4th position. Notably the company’s funding came from a single investor, Summit Partners. Actix delivers wireless network performance solutions. Since the investment the company has released various new new products and signed several agreements with partners/customers worldwide. Oxagen (No. 7), a developer of drugs to treat inflammatory diseases, has also avoided the public eye since its investment. Speedel (No. 8), a developer of therapies for cardiovascular and metabolic diseases went public on the Swiss Stock Exchange in spring 2006.
This leaves two 2004 deals in the Top 10: Symbian (No. 3) and Arakis (No. 10). Symbian has developed the Symbian OS, an operating system for smartphones. It now has over 1,300 employees and offices across Europe, the Far East, India and the US. Arakis was acquired by the Japanese company Sosei in mid 2005 for almost €160 million. As a Sosei subsidiary it is responsible for worldwide research and development, outside of Japan.

|